Julie Steinestel
Papers
2
Total Citations
13
H-Index
2
About
Julie Steinestel is a leading clinical researcher in urologic oncology, with a focused expertise in patient-reported outcomes and treatment decision-making for prostate cancer. Her major contributions center on evaluating the real-world impact of surgical approaches and healthcare certification on patient well-being. In her landmark multicenter IMPROVE study, she demonstrated that patients undergoing robot-assisted radical prostatectomy (RARP) report significantly less regret about their therapy choice compared to those receiving open surgery—a finding that has reshaped counseling practices (9 citations). Steinestel further advanced the field by showing that radical prostatectomy performed in certified prostate cancer centers yields superior patient benefits, including reduced stress urinary incontinence, compared to noncertified centers (4 citations). Her work uniquely bridges surgical technique, healthcare quality assurance, and the patient’s lived experience, making her a pivotal voice in evidence-based urology. By prioritizing endpoints like patient regret and functional outcomes, Steinestel has helped shift the focus from purely oncologic metrics to holistic, patient-centered care. Her research is essential reading for clinicians and researchers aiming to optimize prostate cancer treatment pathways.
Research Focus
Key Achievements
Top Papers
- 1
- 2